William Blair Initiates Coverage of BioAge Labs with Market Perform Rating

On February 28, 2025, William Blair initiated coverage of BioAge Labs (MUN:Y7G) and recommended a Market Perform rating.

Institutional Investment Sentiment

Currently, there are 119 funds and institutions holding positions in BioAge Labs, representing an increase of 45 owners or 60.81% over the last quarter. The average portfolio weight of all funds in Y7G has risen to 0.16%, an increase of 63.44%. Additionally, the total number of shares owned by institutions has grown by 4.11% in the past three months, now totaling 21,663K shares.

Changes Among Major Shareholders

AH Capital Management, L.L.C. holds 3,233K shares, which equates to 9.02% ownership of BioAge Labs. This reflects a growth from its previous holding of 3,014K shares, marking a 6.78% increase. However, the firm’s portfolio allocation to Y7G decreased by 54.41% over the last quarter.

Cormorant Asset Management has increased its holdings to 2,630K shares, now representing 7.34% ownership, up from 1,630K shares, which is a significant 38.03% rise. Nevertheless, the firm also reduced its allocation in Y7G by 53.48% over the last quarter.

Sofinnova Investments remains stable with 2,305K shares, maintaining a 6.43% ownership with no changes reported in the last quarter.

Suvretta Capital Management holds 1,452K shares, accounting for 4.05% ownership. This is a slight decrease from the previous 1,455K shares, signaling a 0.18% decline, and a more substantial 70.40% reduction in their portfolio allocation over the last quarter.

Finally, Tang Capital Management owns 1,318K shares, contributing to a 3.68% ownership of the company.

Fintel serves as a comprehensive investing research platform for individuals, traders, financial advisors, and small hedge funds. Our extensive data encompasses fundamentals, analyst reports, ownership metrics, fund and options sentiment, insider trading, options flow, unusual trades, and more. Our unique Stock picks utilize advanced, backtested quantitative models aimed at enhancing profits.

Click to Learn More

This report originally appeared on Fintel.

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.